Drug Shortage Report for ZERIT - CAP 20MG
| Report ID | 55662 |
| Drug Identification Number | 02216094 |
| Brand name | ZERIT - CAP 20MG |
| Common or Proper name | STAVUDINE |
| Company Name | BRISTOL-MYERS SQUIBB CANADA |
| Market Status | CANCELLED POST MARKET |
| Active Ingredient(s) | STAVUDINE |
| Strength(s) | 20MG |
| Dosage form(s) | CAPSULE |
| Route of administration | ORAL |
| Packaging size | 1 BTL x 60 |
| ATC code | J05AF |
| ATC description | DIRECT ACTING ANTIVIRALS |
| Reason for shortage | Demand increase for the drug. |
| Anticipated start date | 2019-03-25 |
| Actual start date | |
| Estimated end date | 2019-03-25 |
| Actual end date | 2019-03-28 |
| Shortage status | Resolved |
| Updated date | 2019-03-29 |
| Company comments | Product on allocation |
| Health Canada comments | |
| Tier 3 Status | No |
| Contact Address | 2344 BOUL. ALFRED-NOBEL, SUITE 300 ST-LAURENT, QUEBEC CANADA H4S 0A4 |
| Company contact information | For more information please contact the Customer Service Desk at 1-800-267-0005 |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
| Version Number | Date Updated | Language | |
|---|---|---|---|
| v41 | 2019-03-29 | French | Compare |
| v40 | 2019-03-29 | English | Compare |
| v39 | 2019-03-26 | English | Compare |
| v38 | 2019-03-13 | French | Compare |
| v37 | 2019-03-13 | English | Compare |
| v36 | 2019-03-12 | French | Compare |
| v35 | 2019-03-12 | English | Compare |
| v34 | 2019-03-12 | French | Compare |
| v33 | 2019-03-04 | French | Compare |
| v32 | 2019-03-04 | English | Compare |
| v31 | 2019-03-01 | English | Compare |
| v30 | 2019-02-20 | French | Compare |
| v29 | 2019-02-20 | English | Compare |
| v28 | 2019-02-19 | French | Compare |
| v27 | 2019-02-19 | English | Compare |
| v26 | 2019-02-16 | English | Compare |
| v25 | 2019-02-01 | French | Compare |
| v24 | 2019-02-01 | English | Compare |
| v23 | 2019-02-01 | English | Compare |
| v22 | 2019-01-24 | French | Compare |